Meglu ER

Meglu ER

Tablet (Extended Release)

🧬 Metformin Hydrochloride 🏢 UniMed UniHealth Pharmaceuticals Ltd.
Generic Name Metformin Hydrochloride
Manufacturer UniMed UniHealth Pharmaceuticals Ltd.
Unit Price Unit Price: ৳ 6.00 (3 x 10: ৳ 180.00) Strip Price: ৳ 60.00

🔹 Indications

Meglu ER tablet is indicated for the treatment of type 2 diabetes mellitus, particularly in overweight patients when dietary management and exercise alone does not result in adequate glycaemic control.
  • In adults: Meglu ER may be used as monotherapy or in combination with other oral antidiabetic agents or with insulin.
  • In children from 10 years of age and adolescents: Meglu ER may be used as monotherapy or in combination with insulin.
A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure.

🔹 Pharmacology

Meglu ER tablet is indicated for the treatment of type 2 diabetes mellitus, particularly in overweight patients when dietary management and exercise alone does not result in adequate glycaemic control.
  • In adults: Meglu ER may be used as monotherapy or in combination with other oral antidiabetic agents or with insulin.
  • In children from 10 years of age and adolescents: Meglu ER may be used as monotherapy or in combination with insulin.
A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure.

🔹 Dosage & Administration

Meglu ER tablet is indicated for the treatment of type 2 diabetes mellitus, particularly in overweight patients when dietary management and exercise alone does not result in adequate glycaemic control.
  • In adults: Meglu ER may be used as monotherapy or in combination with other oral antidiabetic agents or with insulin.
  • In children from 10 years of age and adolescents: Meglu ER may be used as monotherapy or in combination with insulin.
A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure.

🔹 Interaction

Meglu ER tablet is indicated for the treatment of type 2 diabetes mellitus, particularly in overweight patients when dietary management and exercise alone does not result in adequate glycaemic control.
  • In adults: Meglu ER may be used as monotherapy or in combination with other oral antidiabetic agents or with insulin.
  • In children from 10 years of age and adolescents: Meglu ER may be used as monotherapy or in combination with insulin.
A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure.

🔹 Contraindications

Meglu ER tablet is indicated for the treatment of type 2 diabetes mellitus, particularly in overweight patients when dietary management and exercise alone does not result in adequate glycaemic control.
  • In adults: Meglu ER may be used as monotherapy or in combination with other oral antidiabetic agents or with insulin.
  • In children from 10 years of age and adolescents: Meglu ER may be used as monotherapy or in combination with insulin.
A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure.

🔹 Side Effects

Meglu ER tablet is indicated for the treatment of type 2 diabetes mellitus, particularly in overweight patients when dietary management and exercise alone does not result in adequate glycaemic control.
  • In adults: Meglu ER may be used as monotherapy or in combination with other oral antidiabetic agents or with insulin.
  • In children from 10 years of age and adolescents: Meglu ER may be used as monotherapy or in combination with insulin.
A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure.

🔹 Pregnancy & Lactation

Meglu ER tablet is indicated for the treatment of type 2 diabetes mellitus, particularly in overweight patients when dietary management and exercise alone does not result in adequate glycaemic control.
  • In adults: Meglu ER may be used as monotherapy or in combination with other oral antidiabetic agents or with insulin.
  • In children from 10 years of age and adolescents: Meglu ER may be used as monotherapy or in combination with insulin.
A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure.

🔹 Precautions & Warnings

Meglu ER tablet is indicated for the treatment of type 2 diabetes mellitus, particularly in overweight patients when dietary management and exercise alone does not result in adequate glycaemic control.
  • In adults: Meglu ER may be used as monotherapy or in combination with other oral antidiabetic agents or with insulin.
  • In children from 10 years of age and adolescents: Meglu ER may be used as monotherapy or in combination with insulin.
A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure.

🔹 Pediatric Usage

Meglu ER tablet is indicated for the treatment of type 2 diabetes mellitus, particularly in overweight patients when dietary management and exercise alone does not result in adequate glycaemic control.
  • In adults: Meglu ER may be used as monotherapy or in combination with other oral antidiabetic agents or with insulin.
  • In children from 10 years of age and adolescents: Meglu ER may be used as monotherapy or in combination with insulin.
A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure.

🔹 Storage Conditions

Meglu ER tablet is indicated for the treatment of type 2 diabetes mellitus, particularly in overweight patients when dietary management and exercise alone does not result in adequate glycaemic control.
  • In adults: Meglu ER may be used as monotherapy or in combination with other oral antidiabetic agents or with insulin.
  • In children from 10 years of age and adolescents: Meglu ER may be used as monotherapy or in combination with insulin.
A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure.

💡 Frequently Asked Questions

Meglu ER tablet is indicated for the treatment of type 2 diabetes mellitus, particularly in overweight patients when dietary management and exercise alone does not result in adequate glycaemic control. In adults: Meglu ER may be used as monotherapy...
Meglu ER tablet is indicated for the treatment of type 2 diabetes mellitus, particularly in overweight patients when dietary management and exercise alone does not result in adequate glycaemic control. In adults: Meglu ER may be used as monotherapy...
Meglu ER tablet is indicated for the treatment of type 2 diabetes mellitus, particularly in overweight patients when dietary management and exercise alone does not result in adequate glycaemic control. In adults: Meglu ER may be used as monotherapy...

User Reviews

No reviews yet!
Be the first to share your experience.

Write a Review